Drug stocks mixed, with Vertex in spotlight
June 09, 2011 at 10:48 AM EDT
Drug stocks are mixed in early activity while shares of Vertex sink on weaker-than-expected results from a study for two of its cystic fibrosis drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.